Nanosonics (OTCMKTS:NNCSF – Get Free Report) is expected to be releasing its resultson Tuesday, August 25th. Analysts expect Nanosonics to announce earnings of $0.0171 per share and revenue of $75.7710 million for the quarter.
Nanosonics Stock Performance
Nanosonics stock opened at $2.30 on Friday. Nanosonics has a 1 year low of $2.01 and a 1 year high of $3.06. The firm’s 50 day moving average price is $2.36 and its 200-day moving average price is $2.42.
Nanosonics Company Profile
Nanosonics Limited is an Australia‐based medical technology company specializing in infection prevention solutions for the healthcare sector. Founded in 2001 and headquartered in Sydney, the company is best known for developing and commercializing its proprietary Trophon platform, which provides automated high‐level disinfection of ultrasound probes using sonically activated hydrogen peroxide vapor. Nanosonics holds numerous patents and regulatory approvals across multiple jurisdictions, positioning it as a leader in point‐of‐care decontamination.
The company’s flagship product, Trophon EPR, is designed to address the critical need for rapid, reliable disinfection of endocavity and surface ultrasound transducers.
See Also
- Five stocks we like better than Nanosonics
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Receive News & Ratings for Nanosonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanosonics and related companies with MarketBeat.com's FREE daily email newsletter.
